Assessment of Renal Function in Patients with Elevated BUN and Creatinine

Introduction to Renal Function Assessment

The American College of Cardiology recommends calculating estimated GFR using the MDRD equation, which accounts for age, sex, and race, as serum creatinine alone is unreliable for assessing kidney function in patients, especially the elderly with low muscle mass 1, 3
A BUN/creatinine ratio >20:1 most commonly indicates prerenal azotemia from volume depletion, reduced renal perfusion, or heart failure, rather than intrinsic kidney disease 1, 2

The National Kidney Foundation suggests checking hydration status immediately, looking for orthostatic hypotension, decreased skin turgor, dry mucous membranes, and reduced urine output, to assess for prerenal causes of azotemia 1, 2
Evaluating cardiac function to assess for signs of heart failure is crucial, as heart failure with reduced cardiac output is identified in 36% of hospitalized patients with raised plasma urea 2

The American Heart Association recommends that creatinine increases up to 30% or <3.0 mg/dL are acceptable with ACE inhibitor/ARB therapy and do not require discontinuation, as these represent hemodynamic changes rather than true kidney injury 1, 4
The risk of hyperkalemia increases progressively when serum creatinine exceeds 1.6 mg/dL, and patients on ACE inhibitors/ARBs require close monitoring 4

The National Institute of Diabetes and Digestive and Kidney Diseases suggests monitoring serum creatinine, electrolytes, and estimated GFR every 2-3 months initially in patients with suspected chronic kidney disease 3
Target blood pressure <140/90 mmHg (ideally <130/85 mmHg in patients with renal disease) to slow the progression of kidney disease 3
Immediate nephrology referral is indicated if eGFR <30 mL/min/1.73 m², proteinuria, hematuria, or abnormal urinary sediment are present, or if there is rapidly progressive kidney disease or uncertain etiology of renal impairment after initial workup 1, 2